Metformin use was associated with longer overall survival in a cohort of patients with non-small cell lung cancer and the subgroup of patients with a BMI of 25 or higher but not in patients with a BMI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback